Idexx Laboratories (IDXX) EPS (Basic) (2009 - 2026)

Idexx Laboratories has reported EPS (Basic) for 18 years, with the latest figure at $4.29 in Q2 2026.

• On a quarterly basis, EPS (Basic) rose 17.24% year-over-year to $4.29 in Q2 2026; TTM through Jun 2026 was $14.43, a 17.76% increase from a year earlier, with the FY2025 full-year figure at $13.17, up 22.35% from the prior year.
• EPS (Basic) was $4.29 for Q2 2026 at Idexx Laboratories, up from $3.5 in the prior quarter.
• The five-year high for EPS (Basic) was $4.29 in Q2 2026, with the low at $1.57 in Q2 2022.
• Average EPS (Basic) over 5 years is $2.78, with a median of $2.66 recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: EPS (Basic) tumbled 33.77% in 2022, then jumped 71.61% in 2023.
• Over 5 years, EPS (Basic) stood at $2.06 in 2022, then increased by 13.72% to $2.34 in 2023, then advanced by 11.93% to $2.62 in 2024, then increased by 17.74% to $3.09 in 2025, then surged by 38.9% to $4.29 in 2026.
• The last three EPS (Basic) figures came in at $4.29 (Q2 2026), $3.5 (Q1 2026), and $3.09 (Q4 2025), per Business Quant data.